- Home
- EXEL vs CLMT Comparison
EXEL vs CLMT Comparison
Compare EXEL & CLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- CLMT
- Stock Information
- Founded
- EXEL 1994
- CLMT 1916
- Country
- EXEL United States
- CLMT United States
- Employees
- EXEL N/A
- CLMT N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- CLMT Oil & Gas Production
- Sector
- EXEL Health Care
- CLMT Energy
- Exchange
- EXEL Nasdaq
- CLMT Nasdaq
- Market Cap
- EXEL 11.3B
- CLMT 1.3B
- IPO Year
- EXEL 2000
- CLMT 2006
- Fundamental
- Price
- EXEL $43.62
- CLMT $15.76
- Analyst Decision
- EXEL Buy
- CLMT Strong Buy
- Analyst Count
- EXEL 18
- CLMT 6
- Target Price
- EXEL $43.00
- CLMT $20.17
- AVG Volume (30 Days)
- EXEL 3.4M
- CLMT 1.4M
- Earning Date
- EXEL 08-05-2025
- CLMT 08-08-2025
- Dividend Yield
- EXEL N/A
- CLMT N/A
- EPS Growth
- EXEL 237.58
- CLMT N/A
- EPS
- EXEL 2.20
- CLMT N/A
- Revenue
- EXEL $2,298,922,000.00
- CLMT $4,177,500,000.00
- Revenue This Year
- EXEL $9.37
- CLMT N/A
- Revenue Next Year
- EXEL $11.05
- CLMT N/A
- P/E Ratio
- EXEL $19.80
- CLMT N/A
- Revenue Growth
- EXEL 24.49
- CLMT 0.68
- 52 Week Low
- EXEL $21.82
- CLMT $7.68
- 52 Week High
- EXEL $49.62
- CLMT $25.29
- Technical
- Relative Strength Index (RSI)
- EXEL 55.64
- CLMT 60.38
- Support Level
- EXEL $42.66
- CLMT $14.96
- Resistance Level
- EXEL $44.48
- CLMT $15.95
- Average True Range (ATR)
- EXEL 1.57
- CLMT 0.74
- MACD
- EXEL 0.08
- CLMT -0.08
- Stochastic Oscillator
- EXEL 38.59
- CLMT 53.22
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About CLMT Calumet Specialty Products Partners L.P. Common Units
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.